David A. Meh

1.3k total citations
19 papers, 1.0k citations indexed

About

David A. Meh is a scholar working on Pulmonary and Respiratory Medicine, Hematology and Molecular Biology. According to data from OpenAlex, David A. Meh has authored 19 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 10 papers in Hematology and 2 papers in Molecular Biology. Recurrent topics in David A. Meh's work include Blood properties and coagulation (16 papers), Platelet Disorders and Treatments (7 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). David A. Meh is often cited by papers focused on Blood properties and coagulation (16 papers), Platelet Disorders and Treatments (7 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). David A. Meh collaborates with scholars based in United States, Japan and Belgium. David A. Meh's co-authors include Michael W. Mosesson, Kevin R. Siebenlist, Laurien H. Ulfman, Hartmut Weiler, Mark J. Post, Edward M. Conway, J P DiOrio, Jeffrey I. Weitz, Volkhard Lindner and Brian C. Cooley and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

David A. Meh

19 papers receiving 1.0k citations

Peers

David A. Meh
Oleg V. Gorkun United States
VJ Marder United States
Richard J. Travers United States
A Ludwicka United States
Tatjana Odrljin United States
L. Muylle Belgium
J.J. Huart France
Steven J. Busuttil United States
Oleg V. Gorkun United States
David A. Meh
Citations per year, relative to David A. Meh David A. Meh (= 1×) peers Oleg V. Gorkun

Countries citing papers authored by David A. Meh

Since Specialization
Citations

This map shows the geographic impact of David A. Meh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Meh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Meh more than expected).

Fields of papers citing papers by David A. Meh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Meh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Meh. The network helps show where David A. Meh may publish in the future.

Co-authorship network of co-authors of David A. Meh

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Meh. A scholar is included among the top collaborators of David A. Meh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Meh. David A. Meh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Meh, David A., et al.. (2001). Disintegration and reorganization of fibrin networks during tissue-type plasminogen activator-induced clot lysis. Blood Coagulation & Fibrinolysis. 12(8). 627–637. 24 indexed citations
3.
Mosesson, Michael W., Kevin R. Siebenlist, & David A. Meh. (2001). The Structure and Biological Features of Fibrinogen and Fibrin. Annals of the New York Academy of Sciences. 936(1). 11–30. 471 indexed citations
4.
Meh, David A., Michael W. Mosesson, Kevin R. Siebenlist, et al.. (2001). Fibrinogen Naples I (Bβ A68T) Nonsubstrate Thrombin-Binding Capacities. Thrombosis Research. 103(1). 63–73. 27 indexed citations
5.
Weiler, Hartmut, Volkhard Lindner, Bryce A. Kerlin, et al.. (2001). Characterization of a Mouse Model for Thrombomodulin Deficiency. Arteriosclerosis Thrombosis and Vascular Biology. 21(9). 1531–1537. 127 indexed citations
6.
Siebenlist, Kevin R., Michael W. Mosesson, David A. Meh, et al.. (2000). Coexisting dysfibrinogenemia (gammaR275C) and factor V Leiden deficiency associated with thromboembolic disease (fibrinogen Cedar Rapids).. PubMed. 11(3). 293–304. 35 indexed citations
7.
Siebenlist, Kevin R., David A. Meh, & Michael W. Mosesson. (2000). Position of γ-Chain Carboxy-Terminal Regions in Fibrinogen/Fibrin Cross-Linking Mixtures. Biochemistry. 39(46). 14171–14175. 9 indexed citations
8.
9.
10.
Mosesson, Michael W., Kevin R. Siebenlist, David A. Meh, Joseph S. Wall, & James F. Hainfeld. (1998). The location of the carboxy-terminal region of γ chains in fibrinogen and fibrin D domains. Proceedings of the National Academy of Sciences. 95(18). 10511–10516. 16 indexed citations
11.
Siebenlist, Kevin R., David A. Meh, & Michael W. Mosesson. (1996). Plasma Factor XIII Binds Specifically to Fibrinogen Molecules Containing γ‘ Chains. Biochemistry. 35(32). 10448–10453. 118 indexed citations
12.
Meh, David A., Kevin R. Siebenlist, & Michael W. Mosesson. (1996). Identification and Characterization of the Thrombin Binding Sites on Fibrin. Journal of Biological Chemistry. 271(38). 23121–23125. 108 indexed citations
13.
Meh, David A., et al.. (1995). The dimeric Aα chain composition of dysfibrinogenemic molecules with mutations at Aα 16. Thrombosis Research. 78(6). 531–539. 7 indexed citations
14.
Siebenlist, Kevin R., David A. Meh, Joseph S. Wall, James F. Hainfeld, & Michael W. Mosesson. (1995). Orientation of the Carboxy-terminal Regions of Fibrin γ Chain Dimers Determined from the Crosslinked Products Formed in Mixtures of Fibrin, Fragment D, and Factor XIIIa. Thrombosis and Haemostasis. 74(4). 1113–1119. 12 indexed citations
15.
Siebenlist, Kevin R., David A. Meh, Joseph S. Wall, James F. Hainfeld, & Michael W. Mosesson. (1995). Orientation of the carboxy-terminal regions of fibrin gamma chain dimers determined from the crosslinked products formed in mixtures of fibrin, fragment D, and factor XIIIa.. PubMed. 74(4). 1113–9. 12 indexed citations
16.
Meh, David A., Kevin R. Siebenlist, Gerald Bergtrom, & Michael W. Mosesson. (1993). Comparison of the sequence of fibrinopeptide a cleavage from fibrinogen fragment e by thrombin, atroxin, or batroxobin. Thrombosis Research. 70(6). 437–449. 2 indexed citations
17.
Meh, David A., Kevin R. Siebenlist, Gerald Bergtrom, & Michael W. Mosesson. (1993). The cleavage sequence of fibrinopeptide A from fibrinogen fragment E by thrombin, atroxin or batroxobin.. PubMed. 4(1). 107–12. 3 indexed citations
18.
Amrani, DL, PJ Newman, David A. Meh, & MW Mosesson. (1988). The role of fibrinogen A alpha chains in ADP-induced platelet aggregation in the presence of fibrinogen molecules containing gamma' chains. Blood. 72(3). 919–924. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026